盐酸安罗替尼-话题@MedSci

#盐酸安罗替尼#

6篇内容 | 845人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2199285, encodeId=babc219928587, content=<a href='/topic/show?id=f8fa34032c6' target=_blank style='color:#2F92EE;'>#医学公式#</a> <a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=盐酸安罗替尼手足皮肤反应分级及防治建议点击立即查看, objectType=article, longId=822340, objectId=15088223403c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016400776_4754896.jpg, objectUrl=/article/show_article.do?id=15088223403c, replyNumber=0, likeNumber=3, createdTime=2024-04-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=15088223403c, moduleTitle=盐酸安罗替尼手足皮肤反应分级及防治建议点击立即查看, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15088223403c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198177, encodeId=ff5e21981e74f, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle= 盐酸安罗替尼蛋白尿不良反应分级及防治建议, objectType=article, longId=821379, objectId=a1ed8213e94b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/142214-cognitive-checklist.jpg, objectUrl=/article/show_article.do?id=a1ed8213e94b, replyNumber=0, likeNumber=3, createdTime=2024-04-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a1ed8213e94b, moduleTitle= 盐酸安罗替尼蛋白尿不良反应分级及防治建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1ed8213e94b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2191784, encodeId=e30d2191e842f, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=盐酸安罗替尼出血不良反应分级及防治建议, objectType=article, longId=816306, objectId=1d9981630689, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017217327_4754896.png, objectUrl=/article/show_article.do?id=1d9981630689, replyNumber=0, likeNumber=5, createdTime=2024-03-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1d9981630689, moduleTitle=盐酸安罗替尼出血不良反应分级及防治建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d9981630689)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184570, encodeId=717d21845e053, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=盐酸安罗替尼不良反应剂量调整一般原则, objectType=article, longId=811416, objectId=56a6811416cc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016274166_4754896.png, objectUrl=/article/show_article.do?id=56a6811416cc, replyNumber=0, likeNumber=17, createdTime=2024-01-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=56a6811416cc, moduleTitle=盐酸安罗替尼不良反应剂量调整一般原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56a6811416cc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1460442, encodeId=e9251460442ce, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=盐酸安罗替尼治疗晚期非小细胞肺癌专家共识, objectType=article, longId=156498, objectId=45431564983e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45431564983e, replyNumber=0, likeNumber=33, createdTime=2018-12-25, rootId=0, userName=slcumt, userId=a1c76322331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45431564983e, moduleTitle=盐酸安罗替尼治疗晚期非小细胞肺癌专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45431564983e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460441, encodeId=05fd1460441f7, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=翘首以待：盐酸安罗替尼治疗晚期NSCLC专家共识发布, objectType=article, longId=154861, objectId=8f59154861e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f59154861e6, replyNumber=0, likeNumber=41, createdTime=2018-12-02, rootId=0, userName=slcumt, userId=a1c76322331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f59154861e6, moduleTitle=翘首以待：盐酸安罗替尼治疗晚期NSCLC专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f59154861e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460440, encodeId=129f14604405f, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=治疗非小细胞肺癌新药盐酸安罗替尼胶囊获批上市, objectType=article, longId=138176, objectId=112f1381e6fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=112f1381e6fb, replyNumber=0, likeNumber=42, createdTime=2018-05-16, rootId=0, userName=slcumt, userId=a1c76322331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=112f1381e6fb, moduleTitle=治疗非小细胞肺癌新药盐酸安罗替尼胶囊获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=112f1381e6fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460439, encodeId=27f21460439f7, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=Gene & Cancer Sci：【重磅】盐酸安罗替尼抗血管生成机制详解, objectType=article, longId=134227, objectId=012513422ed4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=012513422ed4, replyNumber=0, likeNumber=46, createdTime=2018-04-05, rootId=0, userName=slcumt, userId=a1c76322331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=012513422ed4, moduleTitle=Gene & Cancer Sci：【重磅】盐酸安罗替尼抗血管生成机制详解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=012513422ed4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460438, encodeId=d34e14604386a, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=招募患者：盐酸安罗替尼胶囊治疗软组织肉瘤的临床研究, objectType=article, longId=56016, objectId=8adb56016b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8adb56016b1, replyNumber=0, likeNumber=36, createdTime=2015-09-11, rootId=0, userName=slcumt, userId=a1c76322331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8adb56016b1, moduleTitle=招募患者：盐酸安罗替尼胶囊治疗软组织肉瘤的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8adb56016b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460437, encodeId=bf51146043e38, content=<a href='/topic/show?id=6a99e2289cd' target=_blank style='color:#2F92EE;'>#盐酸安罗替尼#</a>, objectTitle=招募患者：盐酸安罗替尼治疗转移性结直肠癌的IIb期临床研究, objectType=article, longId=56012, objectId=c4dd5601209, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4dd5601209, replyNumber=0, likeNumber=34, createdTime=2015-09-11, rootId=0, userName=slcumt, userId=a1c76322331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4dd5601209, moduleTitle=招募患者：盐酸安罗替尼治疗转移性结直肠癌的IIb期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4dd5601209)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

盐酸安罗替尼

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#医学公式# #盐酸安罗替尼#

盐酸安罗替尼手足皮肤反应分级及防治建议点击立即查看

2024-04-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

盐酸安罗替尼蛋白尿不良反应分级及防治建议

2024-04-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

盐酸安罗替尼出血不良反应分级及防治建议

2024-03-07发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

盐酸安罗替尼不良反应剂量调整一般原则

2024-01-29发表于上海

slcumt (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

盐酸安罗替尼治疗晚期非小细胞肺癌专家共识

2018-12-25

slcumt (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

翘首以待：盐酸安罗替尼治疗晚期NSCLC专家共识发布

2018-12-02

slcumt (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

治疗非小细胞肺癌新药盐酸安罗替尼胶囊获批上市

2018-05-16

slcumt (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

Gene & Cancer Sci：【重磅】盐酸安罗替尼抗血管生成机制详解

2018-04-05

slcumt (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

招募患者：盐酸安罗替尼胶囊治疗软组织肉瘤的临床研究

2015-09-11

slcumt (审核中...)

前往app查看评论内容

#盐酸安罗替尼#

招募患者：盐酸安罗替尼治疗转移性结直肠癌的IIb期临床研究

2015-09-11

科室
- - 订阅+
  - 更多科室
工具
服务